Ready to ex­pand, Gen­Script rais­es $224M for CD­MO fo­cused on an­ti­bod­ies, cell and gene ther­a­pies

Chi­na’s Gen­Script has brought in new in­vestors to back its bi­o­log­ics-fo­cused sub­sidiary — to the tune of $224 mil­lion.

Gen­Script, which is list­ed in Hong Kong …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER